Hemophilia care in the pediatric age

M Bertamino, F Riccardi, L Banov, J Svahn… - Journal of clinical …, 2017 - mdpi.com
Hemophilia is the most common of the severe bleeding disorders and if not properly
managed since early infancy can lead to chronic disease and lifelong disabilities. However …

Carer burden in rare inherited diseases: a literature review and conceptual model

K Sandilands, A Williams, AJ Rylands - Orphanet Journal of Rare …, 2022 - Springer
Background Carers of people living with rare diseases report heavy burden and a plethora
of unmet needs. A previous parental supportive care needs framework has described the …

[HTML][HTML] Caregiver burden of parents of young children with cystic fibrosis

C Fitzgerald, S George, R Somerville, B Linnane… - Journal of Cystic …, 2018 - Elsevier
Background There is a paucity of research examining the impact of informal caregiving on
parents of young children with cystic fibrosis (CF). The aim of this study was to examine …

The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countries

F Nossair, CD Thornburg - Therapeutic Advances in …, 2018 - journals.sagepub.com
Medical decisions in hemophilia care are primarily related to the type of factor replacement
and treatment regimen. With the growing number of treatment options for patients with …

[HTML][HTML] Improving assessment and management of pain in hemophilia: an Italian Delphi consensus statement

C Santoro, MND Di Minno, A Corcione, G Di Minno… - Blood Reviews, 2022 - Elsevier
Comprehensive evidence-based guidelines and well-validated assessment scales for pain
in people with hemophilia (PwH) are needed. Here, we report 28 statements covering five …

[HTML][HTML] The experiences and attitudes of hemophilia carriers around pregnancy: a qualitative systematic review

MC Punt, TH Aalders, KWM Bloemenkamp… - Journal of Thrombosis …, 2020 - Elsevier
Abstract Background Hemophilia carriers (HCs) face specific psychosocial challenges
related to pregnancy, caused by their inherited bleeding disorder. Optimal support from …

The impact of extended half-life versus conventional factor product on hemophilia caregiver burden

CE Schwartz, VE Powell, J Su, J Zhang… - Quality of Life …, 2018 - Springer
Introduction Extended half-life factor products have reduced annualized bleeding rates in
hemophilia patients. The impact of extended half-life versus conventional factor products on …

Assessment and management of pain in children and adolescents with bleeding disorders: a cross‐sectional study from three haemophilia centres

M Rambod, K Forsyth, F Sharif, K Khair - Haemophilia, 2016 - Wiley Online Library
Introduction Pain is a major clinical problem in patients with bleeding disorders. This study
aimed to determine the level of pain and how it is managed in children and adolescents with …

AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in …

T Matsushita, N Suzuki, A Nagao, C Nagae… - BMJ open, 2022 - bmjopen.bmj.com
Introduction For persons with haemophilia A with factor (F) VIII inhibitors (PwHAwI), immune
tolerance induction (ITI) therapy is indicated for inhibitor eradication; however, since …

Measuring hemophilia caregiver burden: validation of the Hemophilia Caregiver Impact measure

CE Schwartz, VE Powell, A Eldar-Lissai - Quality of Life Research, 2017 - Springer
Aims The purpose of this article is to describe the psychometric development of the
Hemophilia Caregiver Impact measure. Methods Qualitative interviews (n= 22) and a cross …